Secretory Hsp90α intensifies the pathological process through pro-inflammatory effects, while Hsp90 inhibitors can effectively alleviate asthma-induced epithelial barrier dysfunction (Ye et al., 2019; Huang et al., 2024a). Here, HSP90AB1 is linked to asthma.